Article
Efficacy of a T Cell-Biased Adenovirus Vector as a Zika Virus Vaccine
14 Dec 2018
Abstract excerpt
Zika virus (ZIKV) is a major public health concern due to the risk of congenital Zika syndrome in developing fetuses and Guillain-Barre syndrome in adults. Currently, there are no approved vaccines available to protect against infection. Adenoviruses are safe and highly immunogenic vaccine vectors capable of inducing lasting humoral and cellular immune responses. Here, we developed two Adenovirus (Ad) vectored...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
